Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 1

2(22.2%)

Phase 2

1(11.1%)

9Total

N/A(6)

Phase 1(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07472036Not ApplicableCompleted

Improving Breast Cancer Screening Uptake Through Tailored Reminder Letters

Role: collaborator

NCT02649829Phase 1Completed

Autologous Dendritic Cell Vaccination in Mesothelioma

Role: collaborator

NCT05964361Phase 1Active Not Recruiting

First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients

Role: collaborator

NCT06876272Not ApplicableRecruiting

Implementation and Evaluation of Nutrition Interventions

Role: collaborator

NCT06536439Not ApplicableRecruiting

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

Role: collaborator

NCT04688528Not ApplicableRecruiting

Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC

Role: collaborator

NCT01686334Phase 2Active Not Recruiting

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission

Role: collaborator

NCT06152419Not ApplicableUnknown

Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project

Role: collaborator

NCT03956615Not ApplicableCompleted

sdAb-based TRNT of Multiple Myeloma: a Feasibility Study

Role: collaborator

All 9 trials loaded